Quick Contact

Secretariat:
sapmea
Unit 12
202 Glen Osmond Rd
Fullarton SA 5063


Phone: (08) 8274 6048
Fax: (08) 8274 6000
ndlr2012@sapmea.asn.au

Hosted by:

Platinum Sponsor

Gold Sponsor

Silver Sponsor

Sponsors

Welcome

Program now available as PDF (Click Here to Download)

The Scientific and Organising Committees would like to invite you to be a part of the 4th New Directions in Leukaemia Research (NDLR) meeting that will be held on the Sunshine Coast, Queensland, Australia from Sunday March 25th to Wednesday March 28th 2012.

The over-arching goals of the NDLR series of meetings are to bring together scientists and clinicians to discuss and debate current concepts in our understanding of the molecular basis of leukaemia, emerging paradigms and breakthroughs at the forefronts of leukaemia research, and new therapies emerging in the clinic.

The NDLR series of meetings has established an international reputation for bringing together both early-career investigators and senior scientists who employ a broad range of tools, reagents and approaches covering all aspects of molecular and cellular biology. Leukaemia research has undergone an unprecedented revolution in recent years promising a real and significant impact in the clinic. The NDLR Conference is the only biennial series of international meetings focused on leukaemia and therefore offers a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.

We look forward to having you participate in NDLR2012.

Register

Conference Themes:

  • The molecular basis of leukaemia

  • Deregulated intracellular signaling pathways in leukaemia

  • Kinase and phosphatase cascades in leukaemia

  • Transcriptional regulation of leukaemogenesis

  • Small molecule discovery and translation

  • Global analysis of gene and signalling networks

  • Identification of therapeutic targets in leukaemia

  • Kinase inhibitors in the treatment of leukaemia

  • New therapeutics and clinical advances

  • Pre-leukaemic syndromes

  • Antibody therapies

  • Leukaemic stem cells

  • Animal models of leukaemia

  • Genomics of leukaemia